Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

SHE:300639 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	712.36	764.93	1,025	521.97	390.96
Trading Asset Securities	0.63	307.05	387.06	677.14	860
Cash & Short-Term Investments	712.99	1,072	1,412	1,199	1,251
Cash Growth	-33.49%	-24.07%	17.74%	-4.14%	376.86%
Accounts Receivable	1,099	1,891	2,725	1,116	576.86
Other Receivables	10.98	13.56	16.32	14.53	9.57
Receivables	1,110	1,904	2,742	1,131	586.43
Inventory	65.66	99.56	118.74	147.14	96.3
Prepaid Expenses	-	5.1	15.54	23.37	12.01
Other Current Assets	337.39	96.13	112.44	51.95	16.42
Total Current Assets	2,226	3,177	4,400	2,552	1,962
Property, Plant & Equipment	1,408	1,437	1,317	1,168	598.45
Long-Term Investments	545.71	533.12	521.98	273.81	75.98
Other Intangible Assets	259.28	249.58	185.21	100.14	100.72
Long-Term Deferred Tax Assets	86.32	195.35	180.25	29.2	21.07
Long-Term Deferred Charges	60.9	79.95	81.61	82.62	50.65
Other Long-Term Assets	37.61	53.5	54.89	25.58	47.97
Total Assets	4,623	5,726	6,741	4,231	2,857
Accounts Payable	106.75	143.67	466.69	221.15	86.2
Accrued Expenses	67.9	245.73	399.86	174.96	98.07
Short-Term Debt	21.63	2.12	98.48	151.5	75.27
Current Portion of Long-Term Debt	7.91	-	-	-	-
Current Portion of Leases	-	8.86	10.48	6.79	-
Current Income Taxes Payable	13.19	78.1	352.71	94.88	10.83
Current Unearned Revenue	14.86	8.93	22.16	13.16	24.69
Other Current Liabilities	209.32	20.51	12.46	15.15	7.96
Total Current Liabilities	441.55	507.92	1,363	677.59	303.02
Long-Term Debt	52.79	28.27	-	-	-
Long-Term Leases	5.19	17.4	30.53	26.86	0.17
Long-Term Unearned Revenue	9.15	11.82	14.13	16.56	18.91
Long-Term Deferred Tax Liabilities	67.07	61.6	106.14	35.36	0.58
Other Long-Term Liabilities	0.69	0.05	-	-	-
Total Liabilities	576.44	627.05	1,514	756.37	322.69
Common Stock	646.5	649.15	439.52	293.89	235.38
Additional Paid-In Capital	785.49	877.52	1,190	1,280	1,361
Retained Earnings	2,551	3,247	3,258	1,634	851.33
Treasury Stock	-65.13	-100	-149.99	-99.99	-50.02
Comprehensive Income & Other	191.85	187.26	169.84	86.73	-7.63
Total Common Equity	4,109	4,861	4,907	3,194	2,391
Minority Interest	-62.9	237.46	320.38	280.63	143.74
Shareholders' Equity	4,047	5,099	5,228	3,475	2,534
Total Liabilities & Equity	4,623	5,726	6,741	4,231	2,857
Total Debt	87.51	56.65	139.49	185.15	75.44
Net Cash (Debt)	625.47	1,015	1,272	1,014	1,176
Net Cash Growth	-38.40%	-20.20%	25.48%	-13.74%	348.50%
Net Cash Per Share	0.97	1.81	1.93	1.54	1.92
Filing Date Shares Outstanding	636.58	294.06	651.68	655.3	659
Total Common Shares Outstanding	636.58	294.06	651.68	655.3	659
Working Capital	1,784	2,669	3,037	1,875	1,659
Book Value Per Share	6.46	16.53	7.53	4.87	3.63
Tangible Book Value	3,850	4,612	4,722	3,094	2,290
Tangible Book Value Per Share	6.05	15.68	7.25	4.72	3.47
Buildings	-	1,070	991.09	786.57	424.56
Machinery	-	683.89	600.83	521.92	281.13
Construction In Progress	-	171.38	58.62	38.29	49.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.